Main Research and Development Centers
Each of our R&D centers specializes in a different area of scientific exploration. We have several major campuses located throughout the U.S. and U.K.
Andover, Massachusetts
Combining state-of-the-art R&D and Pfizer Global Supply (PGS) facilities with flexible, multi-product manufacturing capabilities, Andover is a key driver of innovation across our biologics discovery, development, and global clinical and commercial supply efforts.
Bothell, WA
Utilizing advanced laboratories and equipment, researchers in Bothell are dedicated to revolutionizing cancer treatment.
Cambridge, Massachusetts
Located in Kendall Square, our Cambridge site interlaces Pfizer’s R&D capability with the densest biomedical community in the world.
Groton, Connecticut
Many of the discoveries and innovations that drive the Pfizer pipeline to new potential occur in the world-class research and development laboratories in Groton.
San Diego, CA
With more than 500,000 square feet of state-of-the-art facilities, this is where our scientists discover and develop cutting-edge cancer therapies using advanced laboratories and equipment.
Pearl River, New York
As the global hub for Pfizer Vaccine Research and Development, our Pearl River colleagues have developed and manufactured vaccines and other medicines for more than a century.
St. Louis, MO
An expansive laboratory and manufacturing space, our colleagues focus on the development of potential new medicines to help prevent or treat diseases and conditions.

Clinical Trials
Learn more about the process of joining a clinical trial and find a trial near you.
Go to Pfizer Clinical Trials Site DetailsRelated Articles
Inside Pfizer’s Fight Against Counterfeit Medicine
The U.S. and Canada combined accounted for more than 2,000 incidents involving counterfeit, diverted, and stolen medicines last year, according to the Pharmaceutical Security Institute (PSI).
August Social Media Round-Up—Q2 Results, AI Adoption, and More
Summer is coming to an end, but here at Pfizer, the work doesn’t stop when the seasons change. Before we say goodbye to the warmer weather, let’s take a look back at the month on Pfizer’s social media.
A Return to Munich: Reflecting on Eight Years of Progress in ATTR-CM
Eight years ago, few people had heard of transthyretin amyloid cardiomyopathy (ATTR-CM), and it was rarely diagnosed in cardiology practice.









